Have a feature idea you'd love to see implemented?
Let us know!
PBH Prestige Consumer Healthcare Inc
Price (delayed)
$84.14
Market cap
$4.16B
P/E Ratio
20.27
Dividend/share
N/A
EPS
$4.15
Enterprise value
$5.17B
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio
Highlights
The quick ratio has increased by 20% YoY and by 12% from the previous quarter
The company's debt fell by 17% YoY and by 3.8% QoQ
Key stats
What are the main financial stats of PBH
Market
Valuations
Earnings
Shares outstanding
49.41M
Market cap
$4.16B
Enterprise value
$5.17B
Price to earnings (P/E)
20.27
Price to book (P/B)
2.41
Price to sales (P/S)
3.76
EV/EBIT
15.93
EV/EBITDA
14.25
EV/Sales
4.65
Revenue
$1.11B
EBIT
$324.23M
EBITDA
$362.53M
Free cash flow
$254.64M
Per share
Balance sheet
Liquidity
EPS
$4.15
Free cash flow per share
$5.13
Book value per share
$34.94
Revenue per share
$22.37
TBVPS
$9.49
Total assets
$3.32B
Total liabilities
$1.59B
Debt
$1.06B
Equity
$1.73B
Working capital
$273.8M
Debt to equity
0.61
Current ratio
3.56
Quick ratio
2.01
Net debt/EBITDA
2.78
Margins
Efficiency
Dividend
EBITDA margin
32.6%
Gross margin
55.2%
Net margin
18.5%
Operating margin
29.3%
Return on assets
6.2%
Return on equity
12.4%
Return on invested capital
22.6%
Return on capital employed
10.1%
Return on sales
29.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PBH stock price
How has the Prestige Consumer Healthcare stock price performed over time
Intraday
1.78%
1 week
1.63%
1 month
18.01%
1 year
44.82%
YTD
37.44%
QTD
16.7%
Financial performance
How have Prestige Consumer Healthcare's revenue and profit performed over time
Revenue
$1.11B
Gross profit
$613.16M
Operating income
$325.37M
Net income
$205.95M
Gross margin
55.2%
Net margin
18.5%
Growth
What is Prestige Consumer Healthcare's growth rate over time
Valuation
What is Prestige Consumer Healthcare stock price valuation
P/E
20.27
P/B
2.41
P/S
3.76
EV/EBIT
15.93
EV/EBITDA
14.25
EV/Sales
4.65
PBH's price to book (P/B) is 34% higher than its 5-year quarterly average of 1.8 and 21% higher than its last 4 quarters average of 2.0
The equity has grown by 13% YoY and by 3% from the previous quarter
The price to sales (P/S) is 50% higher than the 5-year quarterly average of 2.5 and 21% higher than the last 4 quarters average of 3.1
Efficiency
How efficient is Prestige Consumer Healthcare business performance
Prestige Consumer Healthcare's ROIC has increased by 2.3% from the previous quarter
PBH's ROE is down by 2.4% QoQ
Dividends
What is PBH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Prestige Consumer Healthcare financials performed over time
Prestige Consumer Healthcare's total assets is 109% higher than its total liabilities
The quick ratio has increased by 20% YoY and by 12% from the previous quarter
The current ratio is up by 19% year-on-year and by 10% since the previous quarter
The company's debt is 39% lower than its equity
Prestige Consumer Healthcare's debt to equity has decreased by 27% YoY and by 8% from the previous quarter
The company's debt fell by 17% YoY and by 3.8% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.